Sumitomo Mitsui Trust Group’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-521,877
Closed -$39.4M 1102
2026
Q1
$39.4M Sell
521,877
-36,101
-6% -$2.71M 0.03% 507
2025
Q4
$41.6M Sell
557,978
-16,842
-3% -$1.23M 0.02% 522
2025
Q3
$38.8M Sell
574,820
-6,659
-1% -$442K 0.02% 542
2025
Q2
$37.9M Buy
581,479
+50,151
+9% +$3.01M 0.02% 536
2025
Q1
$32.8M Sell
531,328
-12,842
-2% -$851K 0.02% 557
2024
Q4
$39.2M Buy
544,170
+15,820
+3% +$1.24M 0.03% 512
2024
Q3
$43M Buy
528,350
+570
+0.1% +$45.6K 0.03% 483
2024
Q2
$39.2M Sell
527,780
-64,543
-11% -$4.84M 0.03% 492
2024
Q1
$46.2M Sell
592,323
-8,947
-1% -$666K 0.03% 513
2023
Q4
$43M Sell
601,270
-41,088
-6% -$2.86M 0.03% 518
2023
Q3
$44.6M Sell
642,358
-11,793
-2% -$891K 0.04% 484
2023
Q2
$53M Sell
654,151
-93,417
-12% -$7.63M 0.04% 450
2023
Q1
$60.3M Sell
747,568
-332,819
-31% -$26.8M 0.04% 439
2022
Q4
$80.8M Sell
1,080,387
-202,220
-16% -$14.4M 0.06% 350
2022
Q3
$82.8M Sell
1,282,607
-21,400
-2% -$1.48M 0.07% 334
2022
Q2
$90.4M Buy
1,304,007
+421,055
+48% +$31.3M 0.07% 320
2022
Q1
$67.8M Sell
882,952
-112,676
-11% -$8.1M 0.05% 436
2021
Q4
$76.2M Sell
995,628
-25,539
-3% -$1.88M 0.05% 421
2021
Q3
$75.4M Sell
1,021,167
-289,395
-22% -$21.7M 0.05% 422
2021
Q2
$87.4M Sell
1,310,562
-408,259
-24% -$27.3M 0.05% 385
2021
Q1
$128M Sell
1,718,821
-16,614
-1% -$1.26M 0.08% 287
2020
Q4
$126M Buy
1,735,435
+148,541
+9% +$10.5M 0.08% 274
2020
Q3
$105M Buy
1,586,894
+188,958
+14% +$12M 0.07% 294
2020
Q2
$79.7M Sell
1,397,936
-102,611
-7% -$5.03M 0.06% 362
2020
Q1
$52.7M Buy
1,500,547
+318,860
+27% +$15.2M 0.05% 428
2019
Q4
$61.7M Buy
1,181,687
+8,911
+0.8% +$444K 0.05% 402
2019
Q3
$59.2M Buy
1,172,776
+76,347
+7% +$3.76M 0.05% 388
2019
Q2
$52.7M Sell
1,096,429
-36,647
-3% -$1.69M 0.05% 418
2019
Q1
$54.8M Buy
1,133,076
+161,687
+17% +$7.29M 0.05% 391
2018
Q4
$39.3M Buy
971,389
+99,722
+11% +$4.09M 0.04% 459
2018
Q3
$35.7M Buy
871,667
+15,375
+2% +$621K 0.04% 487
2018
Q2
$34M Buy
856,292
+50,495
+6% +$1.94M 0.04% 490
2018
Q1
$30.1M Buy
805,797
+1,810
+0.2% +$73.1K 0.04% 493
2017
Q4
$34.4M Buy
803,987
+6,726
+0.8% +$268K 0.04% 450
2017
Q3
$29.3M Sell
797,261
-22,545
-3% -$910K 0.04% 472
2017
Q2
$37.2M Buy
819,806
+119,995
+17% +$5.3M 0.05% 375
2017
Q1
$29.8M Buy
699,811
+439
+0.1% +$17.9K 0.05% 438
2016
Q4
$28.1M Buy
699,372
+16,365
+2% +$632K 0.05% 445
2016
Q3
$26.5M Sell
683,007
-19,529
-3% -$737K 0.04% 466
2016
Q2
$24.3M Sell
702,536
-19,916
-3% -$690K 0.04% 482
2016
Q1
$24.9M Buy
722,452
+52,179
+8% +$1.82M 0.04% 463
2015
Q4
$26.4M Buy
670,273
+33,330
+5% +$1.3M 0.05% 440
2015
Q3
$24.9M Buy
636,943
+48,604
+8% +$1.93M 0.05% 442
2015
Q2
$22.4M Buy
588,339
+5,344
+0.9% +$187K 0.04% 502
2015
Q1
$19.3M Buy
582,995
+20,177
+4% +$619K 0.03% 546
2014
Q4
$15.1M Buy
562,818
+69,068
+14% +$1.78M 0.03% 573
2014
Q3
$12M Sell
493,750
-89,677
-15% -$2.26M 0.02% 603
2014
Q2
$14.8M Sell
583,427
-95,087
-14% -$2.22M 0.03% 565
2014
Q1
$14.6M Sell
678,514
-1,258
-0.2% -$27.1K 0.03% 565
2013
Q4
$15.2M Sell
679,772
-30,681
-4% -$676K 0.03% 564
2013
Q3
$14.7M Sell
710,453
-9,994
-1% -$213K 0.03% 562
2013
Q2
$13.9M Buy
+720,447
New +$15.1M 0.03% 546

Other funds holding HOLX

Sumitomo Mitsui Trust Group's HOLX Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 521,877 shares — an estimated $39.4M sold.

Sumitomo Mitsui Trust Group first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $128M in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 521,877 Hologic shares in Q2 2026, an estimated $39.4M.
  • Sumitomo Mitsui Trust Group first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Sumitomo Mitsui Trust Group's Hologic position peaked at $128M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.